Wednesday April 19th, 2017 | 1:00-2:00 pm
Law Auditorium | Jordan Medical Education Center (JMEC)
3400 Civic Center Boulevard
5th floor of Perelman Center for Advanced Medicine
Hello, Perelman and Penn Community, we wanted to share this special opportunity with you. We will be hosting a lunch talk with Brent Saunders, President, Chairman, and CEO of Allergan plc, an $80B pharmaceutical company. We will hosting a fireside chat moderated by our very own Dean Morrison, which will make for a very interesting discussion of Allergan and the pharmaceutical industry. This should be an amazing event, and we hope to see you there!
-Penn HealthX Board
Brent Saunders, JD, MBA, was elected Chairman of Allergan plc in 2016, and has served as a Director and as Chief Executive Officer and President from July 2014 to May 2016. He previously served as Chief Executive Officer and President of Forest Laboratories, Inc. and had served as a Director of Forest beginning in 2011. Mr. Saunders has significant healthcare industry expertise and a proven track-record leading business transformations and integrations. Prior to Forest, he served as Chief Executive Officer of Bausch + Lomb Incorporated, a leading global eye health company, serving in this capacity from March 2010 until August 2013. Mr. Saunders also held a number of leadership positions at Schering-Plough, including the position of President of Global Consumer Health Care and was named head of integration for the company’s merger with Merck & Co. and for Schering-Plough’s acquisition of Organon BioSciences. Before joining Schering-Plough, Mr. Saunders was a Partner and Head of Compliance Business Advisory at PricewaterhouseCoopers LLP. Prior to that, he was Chief Risk Officer at Coventry Health Care and Senior Vice President, Compliance, Legal and Regulatory at Home Care Corporation of America. Mr. Saunders began his career as Chief Compliance Officer for the Thomas Jefferson University Health System. Mr. Saunders serves on the Board of Directors at RWJBarnabas Health and is a member of the Business Council and PhRMA. He received a B.A. from the University of Pittsburgh, an M.B.A. from Temple University School of Business, and a J.D. from Temple University School of Law.